China Universal Asset Management »

Pacira Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $261k 8.9k 29.22
2023-12-31 $181k 5.4k 33.74
2023-09-30 $36k 1.2k 30.68
2023-06-30 $24k 602 40.07
2023-03-31 $25k 623 40.81
2022-12-31 $18k 466 38.61
2022-09-30 $23k 429 53.61

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Frontier Capital Management
Dimensional Fund Advisors
Pacer Advisors
Stephens Investment Management Group
ClearBridge Advisors
Rock Springs Capital Management
Rice Hall James & Associates
Geode Capital Management
Baillie Gifford & Co
Marshall Wace
Doma Perpetual Capital Management
Morgan Stanley
Henderson Group

View all funds holding Pacira Pharmaceuticals